SAMBATI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 4.541
AS - Asia 4.052
EU - Europa 2.763
AF - Africa 270
SA - Sud America 246
Continente sconosciuto - Info sul continente non disponibili 246
OC - Oceania 12
Totale 12.130
Nazione #
US - Stati Uniti d'America 4.443
VN - Vietnam 1.263
SG - Singapore 1.017
IT - Italia 870
CN - Cina 841
GB - Regno Unito 537
HK - Hong Kong 315
DE - Germania 312
SE - Svezia 223
FR - Francia 167
BR - Brasile 165
IN - India 138
NL - Olanda 118
BD - Bangladesh 112
RU - Federazione Russa 108
CI - Costa d'Avorio 83
IE - Irlanda 82
KR - Corea 82
FI - Finlandia 74
JP - Giappone 61
CA - Canada 59
TG - Togo 54
ZA - Sudafrica 51
AT - Austria 41
UA - Ucraina 41
SC - Seychelles 39
PL - Polonia 38
TH - Thailandia 35
ID - Indonesia 33
PH - Filippine 33
AR - Argentina 29
EE - Estonia 27
BG - Bulgaria 23
BE - Belgio 22
JO - Giordania 22
TR - Turchia 22
MX - Messico 19
CH - Svizzera 16
IQ - Iraq 14
ES - Italia 12
TW - Taiwan 12
UZ - Uzbekistan 12
EC - Ecuador 10
NG - Nigeria 10
CO - Colombia 9
GR - Grecia 9
EG - Egitto 8
IR - Iran 8
PY - Paraguay 8
VE - Venezuela 8
AU - Australia 7
CL - Cile 7
PK - Pakistan 7
JM - Giamaica 6
TN - Tunisia 6
HR - Croazia 5
PE - Perù 5
RO - Romania 5
SA - Arabia Saudita 5
DZ - Algeria 4
ET - Etiopia 4
LT - Lituania 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
MA - Marocco 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
SI - Slovenia 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IL - Israele 2
IS - Islanda 2
KE - Kenya 2
KH - Cambogia 2
LB - Libano 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GF - Guiana Francese 1
HN - Honduras 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
Totale 11.875
Città #
Singapore 690
Ashburn 530
Southend 433
Fairfield 330
Chandler 309
San Jose 284
Hong Kong 278
Ho Chi Minh City 261
Bologna 256
Hanoi 216
Ann Arbor 202
Woodbridge 170
Houston 166
Hefei 165
Dong Ket 161
Seattle 156
Los Angeles 143
Wilmington 132
Beijing 118
Cambridge 110
Santa Clara 109
Council Bluffs 98
Princeton 94
Boardman 89
New York 89
Dallas 85
Abidjan 83
Dublin 82
Milan 73
Seoul 70
Lauterbourg 68
Lomé 54
Redmond 54
Tokyo 53
Helsinki 52
Buffalo 44
Rome 39
Nanjing 37
Da Nang 36
Frankfurt am Main 35
Haiphong 35
Warsaw 34
Westminster 33
São Paulo 32
Berlin 30
San Diego 30
Turin 30
Vienna 28
Munich 26
Padova 25
Shanghai 23
Florence 22
Orem 22
Sofia 22
Amman 21
Atlanta 20
Brussels 20
Phoenix 20
Johannesburg 19
Redondo Beach 19
Amsterdam 18
Jacksonville 18
Chicago 17
Montreal 17
San Francisco 17
Toronto 17
Bengaluru 16
Nuremberg 16
Shenyang 16
Jakarta 15
Lappeenranta 15
Redwood City 15
Jinan 14
Saint Petersburg 14
Boydton 13
Changsha 13
Hebei 13
Bremen 12
Can Tho 12
Denver 12
Guangzhou 12
London 12
Nanchang 12
Parma 12
Yubileyny 12
Des Moines 11
Falkenstein 11
Mexico City 11
Chennai 10
The Dalles 10
Thái Nguyên 10
Verona 10
Bangkok 9
Boston 9
Hải Dương 9
Jiaxing 9
Quận Bình Thạnh 9
Shijiazhuang 9
Stockholm 9
Brooklyn 8
Totale 7.469
Nome #
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 361
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease 317
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project 305
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 297
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 285
Pervasive and diffuse muscle activity during REM sleep and non-REM sleep characterises multiple system atrophy in comparison with Parkinson's disease 279
Accelerated long-term forgetting in temporal lobe epilepsy: Evidence of improvement after left temporal pole lobectomy 273
Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines 273
Systematic review of studies on exposure to arsenic in drinking water and cognitive and neurobehavioral effects 259
Precuneal Thickness and Depression in Parkinson Disease 255
Are subjective cognitive complaints a risk factor for dementia? 241
Detection of Brain-Derived Cell-Free DNA in Plasma 240
Hypnic jerks are an underestimated sleep motor phenomenon in patients with parkinsonism. A video-polysomnographic and neurophysiological study 236
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 231
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 231
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 228
Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy 223
Human figure drawing distinguishes Alzheimer’s patients: a cognitive screening test study 217
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study 216
Cognitive function in peripheral autonomic disorders 214
A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings 212
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients 212
Slowly progressive aphemia: a neuropsychological, conventional, and functional MRI study 207
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 200
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease 190
The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes 180
Observing movement disorders: best practice proposal in the use of video recording in clinical practice 177
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? 174
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 172
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 171
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients 169
Epigenetic clocks suggest accelerated aging in patients with isolated REM Sleep Behavior Disorder 168
Cognitive and sleep features of multiple system atrophy: review and prospective study 168
Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease 168
The Degree of Cardiovascular Autonomic Dysfunction is not Different in GBA-Related and Idiopathic Parkinson's Disease Patients: A Case-Control Instrumental Evaluation 166
Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation 163
Melanopsin retinal ganglion cell loss in Alzheimer's disease 163
Levodopa‐induced orthostatic hypotension in parkinsonism: A red flag of autonomic failure 156
The treatment of sleep disorders in Parkinson's disease: From research to clinical practice 154
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 152
Cognitive Profile and Its Evolution in a Cohort of Multiple System Atrophy Patients 152
Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course. 144
The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study 143
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 141
Recurrent Reversible Cognitive Impairment in a Cluster Headache Patient: A Case Report 140
Migraine: risk factor and comorbidity. 139
The Italian Framework of Bipolar Disorders in the Elderly: Old and Current Issues and New Suggestions for the Geriatric Psycho-Oncology Research 138
Migraine and cardiovascular diseases. 132
Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: A systematic review 131
Orthostatic hypotension and cognitive impairment: A dangerous association? 128
Diagnosis and management of autonomic failure in neurodegenerative disorders 124
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 122
null 119
Structural and functional frontal‐executive dysfunction in patients with isolated REM sleep behaviour disorder 115
Quantitative Assessment of Motor Response to a Low Subacute Levodopa Dose in the Differential Diagnosis of Parkinsonisms at Disease Onset: Data from the BoProPark Cohort 109
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 106
Visuospatial performance and its neural substrates in Dementia with Lewy Bodies during a pointing task 106
Cognitive and affective disorders in critical SARS-CoV-2 patients and caregivers 105
Exploring Cardiovascular Autonomic Function before and after Chronic Deep Brain Stimulation in Parkinson's Disease 100
Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48 92
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors 91
Syncope 89
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 84
White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study 82
Sex differences in clinical and prognostic trajectories in patients with idiopathic REM sleep behavior disorder: Insights from the FARPRESTO cohort 77
Comment to the article titled: sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson's disease 77
Drug enteric metabolism in gut microbiota-brain crosstalk 75
Oxytocin reduces anger bias, harm-intention recognition, and self-focus in behavioral variant frontotemporal dementia: a randomized double-blind placebo-controlled crossover trial 61
Circadian Rhythms of Sleep–Wake, Thermoregulatory and Cardiovascular Function in Progressive Supranuclear Palsy 57
Multifocal paraneoplastic encephalitis associated with anti-GABA-B and anti-Hu antibodies manifesting with status epilepticus and epilepsia partialis continua: Expanding the clinical-radiological spectrum 56
Pervasive and diffuse muscle activity during rem and nrem sleep differentiates multiple system atrophy and Parkinson's disease 52
Non-motor burden in Isolated REM Sleep Behaviour disorder: systematic evaluation in a prospective cohort 49
Minor Visual Phenomena in Lewy Body Disease: A Systematic Review 46
Why do not all patients with Parkinson disease have RBD? 45
Totale 12.130
Categoria #
all - tutte 32.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.027 0 37 66 66 84 53 40 105 61 119 220 176
2022/20231.140 108 171 55 147 97 94 39 63 188 47 98 33
2023/2024386 43 57 30 35 27 68 16 38 4 30 13 25
2024/20251.556 100 183 137 112 164 67 100 92 63 130 111 297
2025/20264.872 383 416 329 411 494 214 640 206 971 330 242 236
2026/2027462 313 149 0 0 0 0 0 0 0 0 0 0
Totale 12.130